文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,389+ SCI 论文 与阿拉丁产品引用相关
2,303,681.05 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

显示第3217至3228个,产品总数11,257个

切换升序
Co
INORGANIC CHEMISTRY COMMUNICATIONS · 2026 · IF 5.9

Synergistic Co-CoOx dual sites confined in carbon for hydrogen-free hydrodeoxygenation of guaiacol to cyclohexanol

Huaiyue Tong,Weiping Tang,Fei Ge,Xiaohui Yang,Minghao Zhou

Catalytic hydrodeoxygenation (HDO) is a pivotal strategy for upgrading lignin-derived oxygen-rich compounds into value-added chemicals. Developing high-performance non-precious metal inorganic catalysts with precisely controllable active sites remains a core challenge in this field. Herein, we reported a facile one-pot hydrothermal-calcination reduction method to construct carbon-confined Co-CoO x dual-site catalysts (Co x @Sa y -T) using salicylic acid as a bifunctional organic ligand and in-situ carbon source. The optimized Co 5 @Sa 5 –550 catalyst exhibited outstanding performance in the transfer HDO of guaiacol to cyclohexanol, achieving 99.3% guaiacol conversion and 93.5% cyclohexanol selectivity under mild conditions (180 °C, 2 MPa N 2 , 4 h) with isopropanol as the hydrogen donor, eliminating the need for external H2. Comprehensive structural characterizations demonstrated that the superior catalytic activity originates from the synergistic effect of uniformly dispersed Co-CoO x sites. Metallic Co centers catalyzed isopropanol dehydrogenation to generate active hydrogen species, while CoO x species acted as moderate Lewis acid sites to facilitate methoxy group adsorption and C O bond cleavage. This work provided a controllable and scalable strategy for designing efficient non-precious metal inorganic catalysts for biomass valorization.

CAS / MDL: 10026-22-9 69-72-7
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY · 2026 · IF 5.2

Sequential co-delivery of gemcitabine and nintedanib via mPEG-PLG nanomicelles for enhanced breast cancer chemotherapy

Xinyi Zhang,Jingxin Gou,Yanjiao Wang,Xing Tang,Haibing He

The combination of the antiangiogenic agent nintedanib (BIBF) with the antimetabolite gemcitabine (GEM) represents a mechanistically rational yet clinically challenging strategy for breast cancer therapy. However, its clinical translation has been hindered by mismatched pharmacokinetics and the absence of a delivery system capable of coordinating their temporal release profiles. In this study, we developed a polymer-based nanoplatform designed to achieve sequential drug release: rapid initial release of BIBF to modulate the tumor microenvironment, followed by sustained release of GEM to exert cytotoxic effects. The gemcitabine prodrug (mPEG-PLG- GEM) was synthesized via covalent conjugation and subsequently used to prepare dual-loaded nanomicelles (mPEG-PLG-GEM@BIBF) through thin-film hydration. This system exhibited a well-defined sequential release profile in vitro, with BIBF released faster than the GEM prodrug. An optimal synergistic molar ratio (GEM:BIBF = 3:1) was identified. The nanomicelles (∼134.5 nm) enhanced the plasma stability and prolonged the systemic circulation of both drugs (half-lives of GEM increased from 1.38 h to 5.90 h; BIBF from 4.35 h to 8.90 h). Biodistribution studies showed increased tumor accumulation, with the intratumoral GEM:BIBF ratio maintained within the synergistic range around the target ratio of 3:1. In a 4T1 murine breast cancer model, mPEG-PLG-GEM@BIBF achieved a superior tumor inhibition rate of 77.84%, significantly outperforming the free drug combination (50.63%) and GEM monotherapy (33.54%), while also demonstrating a reduced systemic toxicity profile. This work presents a co-delivery nanoplatform designed to coordinate the release and tumor exposure of BIBF and GEM. The improved therapeutic effect is likely associated with the coordinated pharmacokinetics, enhanced tumor accumulation, and BIBF-faster-than-GEM release profile of the nanomicelles. Although direct evidence of vascular normalization and intracellular GEM activation was not obtained in this study, the results support a promising sequential co-delivery strategy for improving GEM/BIBF combination chemotherapy in breast cancer. Download: Download high-res image (206KB) Download: Download full-size image

CAS / MDL: 25952-53-8
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
JOURNAL OF NANOBIOTECHNOLOGY · 2026 · IF 15

Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells

Tian Tingting,Qi Xinxin,Shi Juan,Shang Kaiyu,Shi Huidong,Luo Jiarui,Chai ZhengLong,Li Chuang,Ding Jianbing,Zhu Yuejie,Zhang Fengbo

This study designed and evaluated a chitosan nanoparticle-based mucosal vaccine (CS-CKS9-MEV-DCpep-NPs) targeting M cells and dendritic cells against Brucella . From four immunogenic outer membrane proteins (OMP10, Omp25, Omp31, BtpB), 41 specific epitope peptides were screened and optimized via bioinformatics and ELISPOT for high antigenicity and safety. The dual-targeting strategy uses CKS9 to enhance M cell-mediated antigen uptake and DCpep, together with CS-NPs, to activate DCs and promote their maturation. This coordinates cDC1, cDC2, and pDC subsets, inducing CD8⁺ and CD4⁺ T cell responses and strengthening Th1-biased immunity against intracellular bacteria. The vaccine activates mucosal (sIgA), humoral (IL-21, memory B cells), and cellular (Th1/CTL, central memory T cells) immunity. It significantly reduces bacterial load and tissue damage, offering comprehensive protection. Compared with conventional vaccines, this oral nanovaccine provides high safety, precise targeting, and multi-dimensional immune activation, representing a novel strategy for brucellosis control. Graphical

CAS / MDL: 8049-47-6
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Asian Journal of Pharmaceutical Sciences · 2025 · IF 11.9

Artificial polysaccharide-binding protein mediates co-assembly of nanodrug and probiotics against drug-resistant infectious enteritis

Ying Sun,Jiayue Yang,Zirun Zhao,Suke Liu,Mingchun Li,Qilin Yu

Intestinal drug-resistant pathogens, e.g., Salmonella enterica subsp. enterica serovar Typhimurium (S. Tm) and enteropathogenic Escherichia coli, frequently cause life-threatening infectious enteritis. Probiotic-based therapy is a promising way to eliminate drug-resistant pathogens for treatment of infectious enteritis, but its colonizing and therapeutic efficacy after oral administration are limited. Here, we developed a facile therapeutic agent to treat infectious enteritis by co-assembly of the peptide nanodrug melittin-loaded MSN grafted by polysaccharide-binding protein (MMPB) with the famous probiotic bacteria Lactobacillus plantarum (Lac) and Bifidobacterium animalis subsp. lactis (Bif). The nanodrug was composed of the antimicrobial peptide melittin and mesoporous silica nanoparticles exposing the artificial polysaccharide-binding protein. Owing to presence of the artificial protein on the MMPB surface, the nanodrug strongly bound and cross-linked the probiotic cells, forming the Lac+Bif+MMPB co-assembly. During co-incubation with the kanamycin-resistant E. coli strain (Ecka), the co-assembly strongly reduced the viability of Ecka, leading to the increase in the ratio of probiotic to Ecka from 1.6 to 9.2. After oral administration of the co-assembly to the mice pre-colonized by Ecka, Lac+Bif+MMPB almost eliminated the kanamycin-resistant gene in the intestine, and led to 2-3-fold higher levels of the probiotic cells than the nanodrug MMPB or the combined probiotics Lac+Bif. More importantly, in the mice suffering from enteritis caused by drug-resistant S. Tm, the co-assembly remarkably recovered the mouse body weight, reduced intestine colonization of S. Tm cells, and decreased the levels of pro-inflammatory cytokines in both serum and colons. This study realized the synthetic biology technique-mediated abiotic/biotic co-assembly for efficient treating infectious enteritis induced by drug-resistant pathogens.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
C-Journal of Carbon Research · 2025 ·Vol. 11 ·期 3 ·44 · IF 2.9

Bimetallic Copper–Indium Co-Doped Titanium Dioxide Towards Electrosynthesis of Urea from Carbon Dioxide and Nitrate

Youcai Meng,Tianran Wei,Zhiwei Wang,Caiyun Wang,Junyang Ding,Yang Luo,Xijun Liu

Electrocatalytic urea synthesis offers great potential for sustainable strategies through CO2and NO3−reduction reactions. However, the development of high-performance catalysts is often hampered by the complexity of synthetic methodologies and the unresolved nature of C-N coupling pathways. In this study, we present a copper–indium co-doped titanium dioxide (CuIn-TiO2) catalyst that exhibits remarkable efficacy in enhancing the synergistic reduction of CO2and NO3−to produce urea. The bimetallic CuIn site functions as the primary active site for the C-N coupling reaction, achieving a urea yield rate of 411.8 μg h−1mgcat−1with a Faradaic efficiency of 6.7% at −0.8 V versus reversible hydrogen electrode (vs. RHE). A body of experimental and theoretical research has demonstrated that the nanoscale particles enhance the density of active sites and improve the feasibility of reactions on the surface of TiO2. The co-doping of Cu and In has been shown to significantly enhance electronic conductivity, increase the adsorption affinity for *CO2and *NO3−, and promote the C-N coupling process. The CuIn-TiO2catalyst has been demonstrated to effectively promote the reduction of NO3−and CO2, as well as accelerate the C-N coupling reaction. This effect is a result of a synergistic interaction among the catalyst’s components.

✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
Environmental Science-Nano · 2025 · IF 5.1

Enhancing the proportion of three-coordinated Al active sites on Co/Al2O3 for efficient CF4 decomposition

Heping Chen,Hang Zhang,Xiaojian Wang,Wenjie Luo,Jialin Zheng,Kang Liu,Junwei Fu,Hongmei Li,Zhang Lin,Liyuan Chai,Nan Hu,Min Liu

Aluminum (Al)-based catalysts are the most widely used materials for CF4 catalytic hydrolysis, where three-coordinated Al (AlIII) active sites play a pivotal role in C–F bond activation. The limited proportion of AlIII active sites in conventional Al-based catalysts suppresses their catalytic activity, thereby requiring high temperatures to achieve complete CF4 decomposition. In this work, we developed a Co-modified strategy to enhance CF4 hydrolysis performance by increasing the proportion of AlIII active sites. Structure characterization revealed that Co modification significantly raised the proportion of AlIII sites from 2% (pure Al2O3) to 13%. Temperature-programmed desorption (TPD) analysis showed that the 0.1Co/Al2O3 catalyst exhibits a CF4 adsorption capacity that is 2.0 times higher than that of unmodified Al2O3. Furthermore, in situ diffuse reflectance infrared Fourier-transform spectroscopy (DRIFTS) detected a 2 cm−1 red shift in the characteristic C–F bond peaks on the 0.1Co/Al2O3 catalyst, indicating enhanced C–F bond activation. As a result, the 0.1Co/Al2O3 catalyst achieved 100% CF4 decomposition at 580 °C for over 170 hours, significantly outperforming pure Al2O3 (58% and 20 hours). This work opens up a new approach for developing highly efficient catalysts for CF4 hydrolysis at low temperatures.

CAS / MDL: 10026-22-9
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
ACS Sustainable Chemistry & Engineering · 2025 · IF 7.3

Efficient Electroreduction of High-Pressure Gaseous and Supercritical CO2 to CO in a Zero-Gap Electrolyzer

Xiongwei Tian,Zheng Chen,Francesco Iacoviello,Mengyin Xie,Wenqing Chu,Yuqun Zhuo

The electroreduction of carbon dioxide (CO2R) presents a promising avenue for mitigating CO2 emissions while producing valuable chemicals. In this work, we report a novel pressure equilibrium strategy tailored for pressurized CO2R in a zero-gap electrolyzer, aiming at accommodating the high-pressure CO2 sources from its capture, utilization, and storage scheme. We investigated the impact of pressure on the CO2R performance under both gaseous and supercritical conditions, while also examining the synergistic interplay of temperature with high pressure. Significant enhancement of energy efficiency (46.5%) with high CO Faradaic efficiency (94.4%) and low cell voltage (−2.72 V) was achieved at 200 mA/cm2 under 75 bar and 80 °C. In addition, we noticed that the agglomeration and migration of salt precipitation within the gas diffusion electrode were effectively suppressed under pressurized conditions, which indicated the potential benefit for prolonged cell stability.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
Materials Today Bio · 2025 · IF 10.2

Multivalent Co-assembly of LL37-CpG nanoparticles: Enhanced immune response through activating multiple cell internalization pathways

Yushuang Wei,Wenwen Li,Rong Xu,Cheng Xu,Xiangyang Li,Ning Li,Fengdan Xu,Kai Yang,Bing Yuan

Recent studies have demonstrated that the human antimicrobial peptide LL37 plays a critical role in immune regulation under both normal physiological conditions and during disease progression, as evidenced by its elevated levels observed in various chronic inflammatory diseases. A deeper understanding of its mechanism is essential for elucidating associated physiological and pathological processes, as well as for designing effective immune adjuvants and clinical therapeutics. In this study, we report that LL37 facilitates the assembly of unmethylated CpG dinucleotides (CpG ODNs), a clinically relevant immune adjuvant, into non-crystalline nanoparticles (NPs) with controlled size and zeta potential in a charge ratio-dependent manner. These assembled NPs enter cells via receptor-mediated macropinocytosis, coupled with LL37-mediated membrane penetration, thereby significantly enhancing cellular uptake of CpG compared to CpG alone, which enters cells through clathrin-mediated endocytosis. Consequently, the enhanced internalization of LL37-CpG NPs markedly boosts TNF-α production (>3.5-fold) in macrophages through interactions with lysosomal TLR9. This immunostimulatory mechanism offers an alternative perspective on how LL37 modulates nucleic acid assembly and activates immune cells, providing guidance for the application of peptide-CpG ODN complexes in vaccine adjuvants and immune modulation for disease treatment.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
NEW JOURNAL OF CHEMISTRY · 2025 · IF 2.5

Ionic liquid-assisted synthesis of P- and F-co-doped porous CN for boosting CO2 photoreduction

Xiang Gao,Jiajia Zhao,Hao Song,Xintong Zhou,Yuehua Deng,Jiali Liu,Yanrui Li

Graphitic carbon nitride (CN), a promising photocatalyst for CO2 reduction, suffers from inefficient light harvesting and sluggish charge separation dynamics, which severely restricts its application. Ionic liquids (ILs) have been used for the assisted preparation of photocatalysts, thus effectively altering their geometric and electronic properties. Herein, the 1-butyl-3-methylimidazolium hexafluorophosphate ([Bmim]PF6) IL was introduced as a modifier to successfully construct a P- and F-co-doped porous CN catalyst via simple calcination of the IL and urea without any organic solvents and templates. The optimized catalyst exhibited an enhanced photocatalytic activity for CO2 reduction via gas–solid mode under visible light irradiation, achieving CO and CH4 evolution rates of 39.9 and 2.63 μmol g−1 h−1 (CO selectivity of 94%), which were 7.8 and 4.8 times higher than those of pristine CN, respectively. PFCN also demonstrated excellent reusability and stability. Comprehensive characterization revealed that the strategy of doping of P and F atoms significantly enlarged the surface area, improved CO2 adsorption, broadened visible-light harvesting, and accelerated charge transfer and separation efficiency. This work highlights the potential of ILs as multifunctional agents for designing high-performance doped CN photocatalysts.

CAS / MDL: 57-13-6 64-17-5
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
CHEMICAL ENGINEERING JOURNAL · 2025 · IF 13.2

Synergistic reaction of NH3 selective catalytic reduction and CO oxidation on in-situ sulfated CoMn2O4/CeTiOx

Ning Luo,Fengyu Gao,Hengheng Liu,Lei Yi,Zirong Niu,Erhong Duan,Honghong Yi,Long Sun,Shunzheng Zhao,Yuansong Zhou,Shangfeng Du,Xiaolong Tang

The removal of NOₓ emissions from flue gas by NH 3 selective catalytic reduction (SCR) over catalysts has always been a challenge due to poisoning from the contained water and sulfur. This study demonstrates that rather than poisoning, the contained H 2 O and SO 2 can work positively through an in-situ sulfation process for CoMn 2 O 4 /CeTiOₓ (CMCT) catalysts, thus providing a synergistic effect for CO oxidation and NH 3 -SCR for improving the catalyst activity and selectivity. The obtained sulfated catalyst, achieves over 90 % conversion for NOₓ and about 100 % for CO with nearly 90 % N 2 selectivity at 225–350 °C. The mechanism studies are conducted and the enhanced effect for NH 3 -SCR is revealed from the formed Brønsted acid, surface sulfates, and the reactive oxygen species (O*) generated during CO oxidation. Furthermore, the function of CO adsorption is explored in separating reaction sites and suppressing excessive NH 3 oxidation for achieving high N 2 selectivity.

✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
ELECTROCHIMICA ACTA · 2025 · IF 5.6

Secondary Sulfidation-Engineered Co/N–Graphene Catalyst for Boosted ORR/OER Bifunctionality in Zinc–Air Batteries

Changlei Xia,Hongjie Chen,DongDong Wang,Shilei Ding

The development of highly efficient and stable bifunctional catalysts is of crucial importance for advancing the large-scale application of zinc-air batteries (ZABs). This present study introduces a composite catalyst composed of cobalt-based sulfides supported on nitrogen-doped graphene (Co@NG-S2), synthesized through a two-step sulfurization strategy. The first sulfurization stage was successful in achieving co-doping of sulfur (S) and nitrogen (N) while enhancing the conductivity and activity of the graphene support. The second sulfurization step promoted the uniform distribution of cobalt-based sulfides and strengthened their interfacial coupling with graphene, thereby significantly improving their bifunctional catalytic performance. Electrochemical characterization revealed that Co@NG-S2 exhibited an oxygen reduction reaction (ORR) onset potential of 0.868 V and a half-wave potential (E 1/2 ) of 0.798 V (vs. RHE). For the oxygen evolution reaction (OER), Co@NG-S2 demonstrated a low overpotential of merely 430 mV at a current density of 10 mA cm -2 , thereby demonstrating exceptional ORR/OER bifunctional activity. In addition, a liquid ZAB assembled with this catalyst achieved a peak power density of 110 mW cm -2 and exhibited cycling stability exceeding 200 hours. This study proposes a novel strategy for the synthesis of high-performance transition metal sulfide-carbon-based catalysts, demonstrating considerable promise for future applications.

✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
CATALYSIS LETTERS · 2025 ·Vol. 155 ·期 11 ·1-16 · IF 2.4

Catalytic Reduction of SO2 with CO Over Fe/TiO2 Catalysts: Effect of Pre-sulfurization and Plasma

Yao Liang,Wang Hao,Li Shuangde,Chen Yunfa

Sulfur dioxide (SO 2 ) emissions, a major source of air pollution, can be effectively mitigated through catalytic reduction to elemental sulfur using carbon monoxide (CO). In this study, Fe loaded TiO 2 catalysts were synthesized and subsequently subjected to pre-sulfurization treatment under varied conditions. Their catalytic performance was evaluated in SO 2 reduction for thermal and dielectric barrier discharge (DBD) plasma enhanced thermal catalysis. The results showed that OFS-Fe/TiO 2 catalyst with oxygen-free sulfurization (OFS) treatment exhibited the highest catalytic activity, achieving above 90% SO 2 conversion between 250 and 550 °C under oxygen-assisted reaction (OAR), along with long-term stability under 40–60% water vapor. However, the SO 2 conversion were below 20% for Fe/TiO 2 and oxygen-assisted sulfurization OAS-Fe/TiO 2 catalysts within 250 to 400 °C. Notably, the significantly enhanced catalytic performance of the OFS-Fe/TiO 2 catalyst was probably attributed to the high dispersion of Fe over nano-TiO 2 , the lower Fe 2+ /Fe 3+ ratio, and the formation of active FeS 2 species detected by SEM-EDS, XPS and TPD techniques. Furethermore, a conversion efficiency exceeding 90% was maintained throughout 80 to 550 °C under DBD plasma reaction over POFS-Fe/TiO 2 catalyst with room-temperature DBD plasma oxygen-free sulfurization treatment, surpassing thermal catalysis performance. The significantly enhanced low-temperature activity of plasma catalysis was attributed to the lowest Fe 2+ /Fe 3+ ratio, together with the transformation of FeS 2 into FeS, generating more sulfur vacancies. In-situ DRIFTS experiments confirmed two distinct SO 2 adsorption and reduction mechanisms between Fe/TiO 2 and OFS-Fe/TiO 2 catalysts. The results demonstrate that pre-sulfurization and plasma modification serve as an effective catalytic strategy to enhance CO-mediated SO 2 reduction, offering a sustainable emission control approach through sulfur resource utilization. Graphical

CAS / MDL: 13463-67-7
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。